日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Foundations of systems-based hematology: thematic analysis of expert interviews to guide curriculums and promote growth

系统血液学基础:专家访谈主题分析,以指导课程设置和促进发展

Godby, Richard C; Cogan, Jacob; Cuker, Adam; Garcia, David; Lim, Ming Y; Masias, Camila; May, Jori E; Morton, Colleen T; Schaefer, Jordan K; Shah, Surbhi; Zumberg, Marc S; Marshall, Ariela L

Hidden in the Kidney: Renal-Limited Thrombotic Microangiopathy Without Hemolysis

肾脏中的隐患:无溶血性的肾脏局限性血栓性微血管病

Keratishvili, Diana; Alam, Sreyoshi F; Galeano, Belinda K; Godby, Richard C; Alexander, Mariam P; Bentall, Andrew J

3D Printed Biosponge Adsorbers for Capturing Toxic Chemotherapy Drugs In Situ in the Body

3D打印生物海绵吸附剂用于在体内原位捕获有毒化疗药物

Oh, Hee Jeung; Aboian, Mariam S; Yee, Colin R; Yi, Michael Y J; Maslyn, Jacqueline A; Loo, Whitney S; Kilbride, Bridget; Decavel-Bueff, Emilie; Godby, Adele G; Bhagat, Evan; Wilson, Mark W; Stillson, Carol; Moore, Terilyn; Robbins, Gregory R; Hetts, Steven W

Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

基于既往CD19靶向CAR-T细胞治疗史,评估tafasitamab和来那度胺治疗大B细胞淋巴瘤的疗效。

Merrill, Mwanasha H; Redd, Robert A; Lambert, Nicholas; Caimi, Paolo F; Pullarkat, Priyanka; Godby, Richard C; Bond, David A; Wehmeyer, Graham T; Romancik, Jason; Amoozgar, Behzad; Leslie, Lori; Nastoupil, Loretta J; Crombie, Jennifer L; Abramson, Jeremy S; Khurana, Arushi; Nowakowski, Grzegorz S; Maddocks, Kami; Rutherford, Sarah C; Kahl, Brad; Okwali, Michelle; Buege, Michael J; Batlevi, Connie L; Armand, Philippe; Salles, Gilles; Qualls, David A

Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy

四联疗法治疗新诊断的多发性骨髓瘤中孤立性微小残留病进展的意义

Costa, Luciano J; Medvedova, Eva; Dhakal, Binod; Dholaria, Bhagirathbhai R; Godby, Kelly N; Bal, Susan; Ravi, Gayathri; Giri, Smith; Chhabra, Saurabh; Silbermann, Rebecca; Callander, Natalie S

Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy

为新诊断的多发性骨髓瘤患者建立可衡量的残余疾病轨迹,作为T细胞重定向疗法部署的基准

Bal, Susan; Magnusson, Tylan; Ravi, Gayathri; Giri, Smith; Godby, Kelly; Dhakal, Binod; Callander, Natalie S; Silbermann, Rebecca W; Dholaria, Bhagirathbhai; Reddy, Vishnu B; Costa, Luciano J

Beyond platelet counts: assessing safety of postsplenectomy TPO-RA use in ITP

除了血小板计数之外:评估脾切除术后TPO-RA在ITP患者中的安全性

Alyamany, Ruah; Houghton, Damon E; Sridharan, Meera; Pruthi, Rajiv K; Shah, Surbhi; Godby, Richard C; Wolanskyj-Spinner, Alexandra; Go, Ronald S

Assessment of classical hematologists and classical hematology fellowship programs at NCI-designated cancer centers

对美国国家癌症研究所 (NCI) 指定癌症中心的经典血液学家和经典血液学专科医师培训项目进行评估

Go, Lewis T; Go, Lucas T; Gunaratne, Madugodaralalage D S K; Wolanskyj-Spinner, Alexandra P; Ashrani, Aneel A; Elliott, Michelle A; Godby, Richard L; Hook, Christopher C; Padrnos, Leslie J; Pruthi, Rajiv K; Rivera, Candido E; Rouse, Rachelle L; Shah, Surbhi; Shaikh, Marwan E; Siddiqui, Mustaqeem A; Sridharan, Meera; Wysokinska, Ewa M; Go, Ronald S; Abeykoon, Jithma P

Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience

比较原发性中枢神经系统淋巴瘤诱导治疗后策略的疗效:梅奥诊所的经验

Hwang, Steven R; Godby, Richard C; Negaard, Brianna J; Mwangi, Raphael; Nedved, Adrienne N; Barreto, Jason N; Micallef, Ivana N; Ansell, Stephen M; Porrata, Luis; Durani, Urshila; Thanarajasingam, Gita; Habermann, Thomas M; Maurer, Matthew J; Johnston, Patrick B; Khurana, Arushi

Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis

免疫检查点抑制剂治疗相关性肺炎患者的临床特征、预后及预测模型

Hazim, Antonious; Guiance, Irene Riestra; Shreve, Jacob; Ruan, Gordon; McGlothlin, Damian; LeMahieu, Allison; Haemmerle, Robert; Mcconn, Keith; Godby, Richard C; Kottschade, Lisa; Schwecke, Anna; Fazer-Posorske, Casey; Peikert, Tobias; Edell, Eric; Leventakos, Konstantinos; Egan, Ashley